Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment by Takahashi Hiroki, Suga Moritaka, Kondoh Yasuhiro, Taniguchi Hiroyuki, Ebina Masahito, Ogura Takashi, Taguchi Yoshio, Azuma Arata, Nakata Koichiro, Sato Atsuhiko, Kudoh Shoji, Nukiwa Toshihiro

Get full text

Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation by Minegishi Yuji, Okano Tetsuya, Matsuda Kuniko, Kataoka Kiyoko, Seike Masahiro, Chen Mingwei, Kokubo Yutaka, Kosaihira Seiji, Gemma Akihiko, Noro Rintaro, Yoshimura Akinobu, Kudoh Shoji

Get full text

The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial by Nakata Koichiro, Takahashi Hiroki, Suga Moritaka, Taguchi Yoshio, Ogura Takashi, Azuma Arata, Ebina Masahito, Kondoh Yasuhiro, Taniguchi Hiroyuki, Sato Atsuhiko, Sugiyama Yukihiko, Kudoh Shoji, Nukiwa Toshihiro

Get full text

Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database by Shionoya Aki, Yoshimura Akinobu, Seike Masahiro, Nara Michiya, Noro Rintaro, Minegishi Yuji, Kosaihira Seiji, Seike Yoko, Matsuda Kuniko, Sugiyama Yuka, Li Cai, Gemma Akihiko, Kawakami Akiko, Ogawa Naoki, Uesaka Haruka, Kudoh Shoji

Get full text

Epidemiological characteristics of nontuberculous mycobacteriosis and bronchiectasis: comparative study using national mortality statistics from 1970 to 2015 in Japan by Kozo Morimoto, Kazuro Iwai, Takashi Yoshiyama, Masashi Ito, Fumiko Uesugi, Takanori Asakura, Takeshi Osawa, Koji Furuuchi, Atsuyuki Kurashima, Keiji Fujiwara, Naoki Hasegawa, Yoshiaki Tanaka, Kudoh Shoji, Yuji Shiraishi, Satoshi Mitarai, Manabu Ato, Ken Ohta

Get full text